Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

被引:392
|
作者
House, Michael G. [1 ]
Ito, Hiromichi [1 ]
Gonen, Mithat [2 ]
Fong, Yuman [1 ]
Allen, Peter J. [1 ]
DeMatteo, Ronald P. [1 ]
Brennan, Murray F. [1 ]
Blumgart, Leslie H. [1 ]
Jarnagin, William R. [1 ]
D'Angelica, Michael I. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
关键词
LONG-TERM SURVIVAL; PORTAL-VEIN EMBOLIZATION; LIVER METASTASES; CURATIVE INTENT; EXTRAHEPATIC DISEASE; 2-STAGE HEPATECTOMY; 5-YEAR SURVIVAL; CHEMOTHERAPY; SURGERY; RECURRENCE;
D O I
10.1016/j.jamcollsurg.2009.12.040
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time. STUDY DESIGN: Sixteen-hundred consecutive patients undergoing hepatic resection for metastatic colorectal cancer between 1985 and 2004 were analyzed retrospectively. Patients were grouped into 2 eras according to changes in availability of systemic chemotherapy: era I, 1985 to 1998; era II, 1999 to 2004. RESULTS: There were 1,037 patients in era I and 563 in era II. Operative mortality decreased from 2.5% in era I to 1% in era II (p = 0.04). There were no differences in age, Clinical Risk Score, or number of hepatic metastases between the 2 groups; however, more recently treated patients (era II) had more lymph node positive primary tumors, shorter disease-free intervals, more extrahepatic disease, and smaller tumors. Median follow-up was 36 months for all patients and 63 months for survivors. Median and 5-year disease-specific survival (DSS) were better in era II (64 months and 51% versus 43 months and 37%, respectively; p < 0.001); but median and 5-year recurrence-free survival (RFS) for all patients were not different (23 months and 33% era II versus 22 months and 27% era I; p = 0.16). There was no difference in RFS or DSS for high-risk (Clinical Risk Score >2, n = 506) patients in either era. There was a marked improvement in both RFS and DSS for low risk (Clinical Risk Score 2, n = 1,094) patients. CONCLUSIONS: Despite worse clinical and pathologic characteristics, survival but not recurrence rates after hepatic resection for colorectal metastases have improved over time and might be attributable to improvements in patient selection, operative management, and chemotherapy. The improvement in survival over time is largely accounted for by low-risk patients. (J Am Coll Surg 2010; 210:744-754. (C) 2010 by the American College of Surgeons)
引用
收藏
页码:744 / 752
页数:9
相关论文
共 50 条
  • [21] Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
    Zhang, Hang-Yu
    Guo, Jian-Hai
    Gao, Song
    Chen, Hui
    Wang, Xiao-Dong
    Zhang, Peng-Jun
    Liu, Peng
    Cao, Guang
    Xu, Hai-Feng
    Zhu, Lin-Zhong
    Yang, Ren-Jie
    Li, Jian
    Zhu, Xu
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 10 (11) : 431 - 438
  • [22] Preoperative Chemotherapy and the Risk of Hepatotoxicity and Morbidity after Liver Resection for Metastatic Colorectal Cancer: A Single Institution Experience
    Wolf, Patrick S.
    Park, James O.
    Bao, Fei
    Allen, Peter J.
    DeMatteo, Ronald P.
    Fong, Yuman
    Jarnagin, William R.
    Kingham, T. Peter
    Goenen, Mithat
    Kemeny, Nancy
    Shia, Jinru
    D'Angelica, Michael I.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 216 (01) : 41 - 49
  • [23] SURVIVAL IMPACT OF THE INTRODUCTION OF OXALIPLATIN AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER: A SINGLE INSTITUTION EXPERIENCE
    Oliveira, M.
    Dionisio, M.
    Esteves, S.
    Oliveira, J.
    Moreira, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 62 - 63
  • [24] Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer
    Arru, Marcella
    Aldrighetti, Luca
    Castoldi, Renato
    Di Palo, Saverio
    Orsenigo, Elena
    Stella, Marco
    Pulitano, Carlo
    Gavazzi, Francesca
    Ferla, Gianfranco
    Di Carlo, Valerio
    Staudacher, Carlo
    WORLD JOURNAL OF SURGERY, 2008, 32 (01) : 93 - 103
  • [25] Analysis of Prognostic Factors Influencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
    Marcella Arru
    Luca Aldrighetti
    Renato Castoldi
    Saverio Di Palo
    Elena Orsenigo
    Marco Stella
    Carlo Pulitanò
    Francesca Gavazzi
    Gianfranco Ferla
    Valerio Di Carlo
    Carlo Staudacher
    World Journal of Surgery, 2008, 32 : 93 - 103
  • [26] Decreased Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Compared to Hepatic Resection for Metastatic Colorectal Cancer
    Blackham, A.
    Russell, G. B.
    Stewart, J. H.
    Votanopoulos, K.
    Levine, E. A.
    Shen, P.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S95 - S96
  • [27] Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades A Single-Institution Experience
    Konstantinidis, Ioannis T.
    Deshpande, Vikram
    Genevay, Muriel
    Berger, David
    Fernandez-del Castillo, Carlos
    Tanabe, Kenneth K.
    Zheng, Hui
    Lauwers, Gregory Y.
    Ferrone, Cristina R.
    ARCHIVES OF SURGERY, 2009, 144 (05) : 441 - 447
  • [28] Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution
    Sudo, Makoto
    Furuya, Shinji
    Shimizu, Hiroki
    Nakata, Yuuki
    Iino, Hiroshi
    Shiraishi, Kensuke
    Akaike, Hidenori
    Hosomura, Naohiro
    Kawaguchi, Yoshihiko
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Inoue, Shingo
    Kono, Hiroshi
    Ichikawa, Daisuke
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17
  • [29] Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution
    Makoto Sudo
    Shinji Furuya
    Hiroki Shimizu
    Yuuki Nakata
    Hiroshi Iino
    Kensuke Shiraishi
    Hidenori Akaike
    Naohiro Hosomura
    Yoshihiko Kawaguchi
    Hidetake Amemiya
    Hiromichi Kawaida
    Shingo Inoue
    Hiroshi Kono
    Daisuke Ichikawa
    World Journal of Surgical Oncology, 17
  • [30] Clinical Outcomes after Surgical Resection of Colorectal Cancer in 1,294 Patients
    Luo, Yanxin
    Cui, Ji
    Wang, Lei
    Chen, Chuangqi
    Song, Shunxin
    Huang, Meijin
    Peng, Junsheng
    Lan, Ping
    Huang, Yihua
    Wang, Jianping
    HEPATO-GASTROENTEROLOGY, 2012, 59 (117) : 1398 - 1402